Discovery will save lives
on: February 5, 2008, 11:44 am
Release Author: James M Sleighter / President
Release Summary: Imagine being able to detect breast and prostate
cancer at it's earliest stage, or even before it begins.
Release Body: ViroTech LLC announces its breakthrough cancer
LLC announces its breakthrough discovery of the new HIV-like
human cancer virus. The company’s Vice President,
Dr. Eva M. Rakowicz-Szulczynska has discovered and described
this retrovirus several years ago but official classification of
this new retrovirus was just recently approved by the National
Center for Biotechnology Information. Genetic sequences
and proteins of the virus were already deposited in the GenBank
and are known in literature as Rakowicz (RAK) markers
or RAK genes and RAK antigens.
This novel virus is exogenous, and probably has derived from the
same ancestor as HIV. ViroTech LLC has proved that
the HIV-like human cancer virus stays invisible
in the DNA of blood lymphocytes of many currently healthy people.
When the new virus becomes active, it relocates to the reproductive
organs, including breast, ovary, uterus, and vulva in women and
prostate or testis in men, starting the process of malignant transformation.
There are many known infectious cancer viruses in animals, and some
viruses are also known to be associated with human cancers. However,
in contrast to any other human viruses, which show only some links
to cancer, this new HIV-like human cancer virus
is present in 100% of breast, ovarian, uterine and prostate cancer
cases, while it is completely absent in healthy tissues, and in
the blood of non-infected individuals.
ViroTech LLC has developed and clinically tested
a novel comprehensive diagnostic system, which allows detection
of the gene RAK alpha of this HIV-like
human cancer virus long before cancer develops. Inexpensive
and non-invasive blood tests are developed by ViroTech LLC
for the virus detection.
ViroTech LLC has also developed other diagnostic
tests to monitor virus activation and relocation to specific organs.
For example, detection of the viral DNA in the tissue biopsy can
be monitored much earlier than cancer is detected by traditional
pathological tests. New diagnostic tests would allow starting therapy
even before cancer develops. In the future, peptide vaccines and
DNA vaccines would be developed for cancer prevention.
ViroTech LLC has successfully completed pre-clinical
and clinical evaluation of its proprietary diagnostic tests in the
USA and Europe, while using over 4000 volunteers. With NCBI-GenBank
official classification of this novel lentivirus, ViroTech
LLC expects to get expedited regulatory approvals from
the Food and Drug Administration. The final confirmatory trials
for the first breast cancer test kit have to be performed under
FDA supervision in three independent US cancer centers with 200
patients per center, giving a total of 600 altogether. ViroTech
LLC expects to complete the first part of the trials within
eight months and the final part within a few months later. Assuming
funding is raised early in 2008, final approval by the FDA is expected
by the end of the last quarter of 2009, with sales beginning in
The company has protected its core intellectual property by means
of a number of key patents. These allow the company to exclusively
utilize MAb RAK BrI, as well as also protect a
number of other key compounds.
There is little direct competition to ViroTech LLC
in terms of its technology, rather ViroTech LLC
is competing against existing techniques. ViroTech LLC’s
approach is cheaper and more accurate than current approaches, such
as mammograms. In addition, ViroTech LLC’s
technology is the only one which allows detecting pre-cancerous
changes occurring in reproductive organs of the currently healthy
Substantial equity in the company is available through a private
stock offering and multibillion dollar markets should be anticipated.
ViroTech LLC is currently reviewing sites in Daytona
Beach, Florida for a new research Laboratory to continue work on
this amazing discovery.
Details: James M Sleighter
Health Food Hut Inc
1024 North Atlantic Ave
Daytona Beach, Florida 32117
Your health is your biggest asset......
to previous page...
to home page...
your press releases...